Market closedNon-fractional
Stereotaxis/STXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Stereotaxis
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Ticker
STXS
Sector
Healthcare
Trading on
AMEX
Industry
Health Care Equipment and Supplies
Headquarters
Saint Louis, United States
Employees
122
Website
www.stereotaxis.com
Stereotaxis Metrics
BasicAdvanced
$168M
Market cap
-
P/E ratio
-$0.26
EPS
1.53
Beta
-
Dividend rate
Price and volume
Market cap
$168M
Beta
1.53
Financial strength
Current ratio
2.428
Quick ratio
1.68
Long term debt to equity
24.687
Total debt to equity
26.898
Management effectiveness
Return on assets (TTM)
-29.07%
Return on equity (TTM)
-80.58%
Valuation
Price to revenue (TTM)
6.206
Price to book
11.52
Price to tangible book (TTM)
11.52
Price to free cash flow (TTM)
-19.332
Growth
Revenue change (TTM)
-2.01%
Earnings per share change (TTM)
-5.13%
3-year revenue growth (CAGR)
-2.78%
3-year earnings per share growth (CAGR)
36.56%
What the Analysts think about Stereotaxis
Analyst Ratings
Majority rating from 6 analysts.
Stereotaxis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.8M
51.11%
Net income
-$4.5M
-10.00%
Profit margin
-66.17%
-40.45%
Stereotaxis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.07
-$0.07
-$0.07
-$0.06
-
Expected
-$0.07
-$0.06
-$0.07
-$0.06
-$0.05
Surprise
-3.05%
15.51%
6.06%
-3.23%
-
Stereotaxis News
AllArticlesVideos
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
GlobeNewsWire·4 days ago
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
GlobeNewsWire·1 week ago
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Stereotaxis stock?
Stereotaxis (STXS) has a market cap of $168M as of July 26, 2024.
What is the P/E ratio for Stereotaxis stock?
The price to earnings (P/E) ratio for Stereotaxis (STXS) stock is 0 as of July 26, 2024.
Does Stereotaxis stock pay dividends?
No, Stereotaxis (STXS) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Stereotaxis dividend payment date?
Stereotaxis (STXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Stereotaxis?
Stereotaxis (STXS) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Stereotaxis stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.